Washington, D.C., February 8, 2017 – Infinitesimal, LLC ( was awarded the New Product Award at the SLAS 2017 conference ( The award was given to three companies, out of 40 entries, with the most innovative new products. For its share, Infinitesimal presented the NFP-ETM technology, an automated platform for single cell transfection using localized electroporation. The system consists of an inverted optical microscope, a robotic arm, and a microfluidic probe controlled via custom electronics and proprietary software. Using point and click technology, the user selects individual cells to be transfected, and the NFP-ETM probe then moves automatically to each cell to deliver its cargo. The system uses a patented automatic contact algorithm to detect contact with the cell membrane, at which point the electroporation is performed via low-voltage pulses. Using the system, gene editing, temporal gene activation, and cell line generation have been demonstrated. The platform is available immediately for beta-testing and will be available for sale in August of 2017. If you are interested in learning more about the NFP-ETM technology or would like to request a demo, please contact the company at

Feb 2017 – Infinitesimal’s Vincent Lemaitre and Jonathon Prinz were interviewed by the Lab Man, Steve Hamilton, after winning the New Product Award at SLAS2017. Click the following link to learn more

Feb 2017 – Infinitesimal attended the SLAS2017 International Conference and Exhibition in Washington D.C. where members of the team exhibited the Nanofountain Probe Electroporation (NFP-E) System at their Innovation AveNEW booth. Infinitesimal’s Jonathon Prinz pitched the product in a Late Night with LRIG rapid-fire session during Monday night. Infinitesimal’s Vincent Lemaitre presented a lecture on the biological applications of the NFP-E during a Tuesday afternoon session. Infinitesimal was honored when selected to receive the New Product Award by the SLAS committee.

May 2015 – Infinitesimal received a Phase II SBIR grant of $1,000,000 from the National Institutes of Health. This grant will support development of automated single-cell electroporation using the nanofountain probe electroporation system.

Oct 2014 – Infinitesimal received a Phase I SBIR grant to develop a localized electroporation microfluidic device platform.

Aug 2013 – Infinitesimal has received a Phase II SBIR grant of $475,100 from the National Science Foundation. This grant will support research for further development of the nanofountain probe electroporation system coupled with microwell arrays for single-cell isolation and cell line development.